Selective disappearance of histamine H2-receptor activity in the human gastric cancer cell line HGT-1 after short-term or chronic treatment by histamine or its H2-antagonists
- 1 April 1985
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 16 (3-4) , 195-198
- https://doi.org/10.1007/bf01983137
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activityBiochemical and Biophysical Research Communications, 1984
- Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1Life Sciences, 1983
- Regulation by Vasoactive Intestinal Peptide, Histamine, Somatostatin-14 and -28 of Cyclic Adenosine Monophosphate Levels in Gastric Glands Isolated from the Guinea Pig Fundus or Antrum*Endocrinology, 1983
- Comparison of antisecretory potency and duration of action of the H2-receptor antagonists AH 22216, cimetidine, ranitidine and SK & F 93479 in the dogInflammation Research, 1983
- Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileumFEBS Letters, 1982
- The interaction of glucagon, gastric inhibitory peptide and somatostatin with cyclic AMP production systems present in rat gastric glandsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1982
- CHARACTERIZATION OF A NEWLY ESTABLISHED HUMAN GASTRIC-CANCER CELL-LINE HGT-1 BEARING HISTAMINE H-2-RECEPTORS1982
- Regulation by vasoactive intestinal peptide of cyclic amp accumulation in gastric epithelial glandsFEBS Letters, 1980